Work

A phase II basket study of the oral TRK inhibitor LOXO–101 in adult subjects with NTRK fusion-positive tumors

Year: 2016

Type: article

Study design: Clinical Trial

Source: Annals of Oncology

DOI: 10.1093/annonc/mdw368.52

Authors: A. Drilon, D. Hong, J. Deeken, S. Smith, M. Reynolds, S. Cruickshank, M. Deegan, N. Ku, D. Hyman

Institutions: Memorial Sloan Kettering Cancer Center, The University of Texas MD Anderson Cancer Center, Inova Fairfax Hospital, Loxo Oncology at Lilly (United States)

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2588002723

FWCI:

Cites:

Cited by: 4

Related to: 10